Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2026-05-16 @ 6:09 PM
Study NCT ID:
NCT00309556
Status:
COMPLETED
Last Update Posted:
2011-12-30
First Post:
2006-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer
Sponsor:
Organization: